![](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fabstract-1.47f9baf3.jpg&w=3840&q=75)
![](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fabstract-2.6f0156c8.jpg&w=3840&q=75)
![](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fabstract-3.b34a9166.jpg&w=3840&q=75)
Clinical Trial Awareness Boost
An innovative strategy increased awareness and clinical trial participation, enhancing stakeholder relationships and trial success.
Capabilities: Medical
Audiences: HCPs, Medical Affairs Teams
![](https://images.ctfassets.net/s5qqrp96y1p4/73wrFN2d01c4yLcStzbjci/359e86fc51e02326fdaa8f54fe16240e/Clinical_Trial_Awareness_Boost_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Patient Engagement Beyond the Pill
A personalized patient support program addressed adherence challenges through behavioral insights, innovative communication channels, and tailored content delivery.
Capabilities: Patient Support Programs
Audiences: Patients, Care Partners
![](https://images.ctfassets.net/s5qqrp96y1p4/5MOUZ8oyTDuKe0hnbWqnhC/003c8e02e1f2dcadfee930dd9415e0d2/Patient_Engagement_Beyond_Pill_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
HCP-Driven Omnichannel Market Activation
An omnichannel approach successfully launched a new rare disease treatment, achieving cost savings and increased patient adoption.
Capabilities: Digital and OmniCx Transformation
Audiences: IT, Enterprise
![](https://images.ctfassets.net/s5qqrp96y1p4/7aHJeDQw5vWHMMlD9eLPzn/8cf9a4ccc2f6491e9e2165e0295efb22/HCP-Driven_Omnichannel_Market_Activation_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Setting a New Standard of Care
A strategic marketing plan helped an emerging biotech brand stand out in a competitive market, increasing visibility while reshaping patient and HCP expectations.
Capabilities: Medical, Brand Strategy, Creative, Activation Strategy, Media
Audiences: HCPs, Patients, Branded, Unbranded
![](https://images.ctfassets.net/s5qqrp96y1p4/AteaCGZurIMW2u3WClrYj/8fcf0bbed9b3dd9591e4d101b5366b26/Setting_a_New_Standard_of_Care_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Medical Device Market Launch
An omnichannel strategy enhanced HCP engagement, ensuring a successful market introduction and improved ROI.
Capabilities: Digital and OmniCx Transformation, Brand Strategy, Activation Strategy, Media
Audiences: HCPs
![](https://images.ctfassets.net/s5qqrp96y1p4/2g5gInOVzGbjS4Nf88izrN/b4f250a9b8c8cc87bebb1bf186deebcb/Medical_Device_Market_Launch_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Engaging Rare Disease Community
A gaming-inspired digital campaign boosted engagement for a rare disease portal, leading to increased retention and high interaction levels.
Capabilities: Activation Strategy, Media
Audiences: Patients, Care Partners
![](https://images.ctfassets.net/s5qqrp96y1p4/68hb89BnNxo8xZitGNZIru/69f59c3b1df82440ef0f9165fb780697/Engaging_Rare_Disease_Community_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Educating HCPs on Innovative Therapies
A strategic communication platform improved awareness and adoption of innovative rare disease therapies among HCPs.
![](https://images.ctfassets.net/s5qqrp96y1p4/6dYw16yPRtIUYPf4laNbuX/c67f9bafca5e925317a275de6badb09f/Educating_HCPs_on_Innovative_Therapies_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Optimizing Rare Disease Engagement for HCPs
A new medical Affairs model optimized HCP engagement, improving communication and supporting successful product launches.
Capabilities: Medical
Audiences: HCPs, Medical Affairs Teams
![](https://images.ctfassets.net/s5qqrp96y1p4/grxWL0fDO17qkWiUdoqOp/ed4027618de50a3a1be05c0b218303fa/Optimizing_Rare_Disease_Engagement_for_HCPs_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)
Global Omnichannel Strategy
A tailored omnichannel strategy modernized customer engagement across global markets. The approach increased stakeholder engagement and supported clinical trial participation.
Capabilities: Digital and OmniCx Transformation
Audiences: IT, Enterprise
![](https://images.ctfassets.net/s5qqrp96y1p4/2zu8llXmXXuY3yXJl1CGkX/661365ecc9fc1b9463dcabf060b53027/Global_Omnichannel_Strategy_HEADER.jpg?w=960&q=85&fm=jpg&fl=progressive)